Ceribell (NASDAQ: CBLL) CEO sells 39K shares after option exercise
Rhea-AI Filing Summary
Ceribell, Inc. President and CEO Xingjuan Chao reported a combination of stock option exercises and open-market sales of Common Stock. On June 8, 2026, she exercised options to acquire 25,000 shares of Common Stock at an exercise price of $4.70 per share and sold a total of 39,000 shares of Common Stock in open-market transactions at a weighted average price of approximately $18.33 per share, with individual sale prices ranging from $18.15 to $18.75.
Following these transactions, she held 816,317 shares of Common Stock directly. In addition, 369,088 shares of Common Stock were held indirectly through the ACP 2021 Trust, where she serves as co-trustee and may be deemed to share beneficial ownership, while disclaiming beneficial ownership except to the extent of her pecuniary interest. The stock options exercised carry a $4.70 exercise price and an expiration date of February 16, 2033, and are described as fully vested and currently exercisable. The filing notes that the sale transactions were effected pursuant to a Rule 10b5-1 trading plan, indicating they were executed under a pre-arranged trading program.
Positive
- None.
Negative
- None.
Insights
CEO executes option exercise-and-sell under 10b5-1; net routine trimming.
The CEO of Ceribell, Inc., Xingjuan Chao, exercised stock options with a $4.70 exercise price to acquire 25,000 Common shares, then sold 39,000 shares at a weighted average price around $18.33. This pattern represents a classic exercise-and-sell sequence, monetizing part of an equity award.
After the transactions, she still directly holds 816,317 Common shares, plus indirect exposure through 369,088 shares held by the ACP 2021 Trust. In proportional terms, the net sale is a small fraction of her visible equity position, suggesting a routine liquidity event rather than a major shift in exposure.
The filing states that the sales occurred pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Such pre-arranged plans are established in advance and help separate trading activity from short-term information, which typically reduces the informational content of the trade timing for outside investors.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,446 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 23,554 | $0.00 | -- |
| Sale | Common Stock | 14,000 | $18.33 | $257K |
| Exercise | Common Stock | 1,446 | $4.70 | $7K |
| Sale | Common Stock | 1,446 | $18.33 | $27K |
| Exercise | Common Stock | 23,554 | $4.70 | $111K |
| Sale | Common Stock | 23,554 | $18.33 | $432K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.15 to $18.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The stock option is fully vested and currently exercisable.